Oslo Cancer Cluster Incubator: from offices to shared labs

Oslo Cancer Cluster is an oncology research and industry cluster dedicated to improving the lives of cancer patients by accelerating the development of new cancer diagnostics and treatments. It is a national non-profit member organisation with about 100 members. The member base comprises university hospitals, research centres, patient organisations, start-ups and biotech companies, global pharma and technology companies, investors, financial institutions as well as service providers – all working in the cancer field. Jointly, they cover the entire oncology value chain – from exploratory research to delivering novel therapeutics and diagnostics to patients worldwide.

Around 30 of the members are gathered in the Oslo Cancer Cluster Incubator, situated in the Oslo Cancer Cluster Innovation Park in the Ullern district of Oslo. Oslo Cancer Cluster is part of the wider Oslo Science City initiative that was featured in our 30 September 2022 edition, in our interview with CEO Christine Wergeland Sørbye. Oslo Science City is Norway’s first innovation district, and it is built around four thematic areas where the actors in Oslo Science City have world-leading knowledge: Health and life sciences, Climate, energy and environment, Digitalisation and computational science and Democracy and inclusion.

Conversion Journey of Cluster Incubator